Finance

Lists
Why is TDOC up 2.60%?
Dive Deeper
TDOC:NYSE
Teladoc Health Inc
$ 5.92
+2.60%
(+0.15) 1D
$ 5.90
-0.34% (-0.020)
After hours
Closed: 10-р сарын 12, 16:00:03 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TDOC...
Open
$ 5.82
High
$ 5.98
Low
$ 5.73
Mkt. cap
1.08 тэрбум
Avg. vol.
3.58 сая
Volume
2.47 сая
52-wk high
$ 9.89
52-wk low
$ 4.40
EPS
-$ 0.99
Beta
2.14
Shares outstanding
181.68 сая
No. of employees
5 мян
Open
$ 5.82
High
$ 5.98
Low
$ 5.73
Mkt. cap
1.08 тэрбум
Avg. vol.
3.58 сая
Volume
2.47 сая
52-wk high
$ 9.89
52-wk low
$ 4.40
EPS
-$ 0.99
Beta
2.14
Shares outstanding
181.68 сая
No. of employees
5 мян
News stories
From web sources and news partners
Profile
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services. The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025. Wikipedia
About Teladoc Health Inc
CEO-
Employees5.12 мян
Founded2002
Headquarters-
SectorHealth care
Analyst ratings
Based on 16 analysts giving stock ratings to TDOC in the past 3 months
Hold
Buy
4
Hold
12
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for TDOC in the last 3 months.
Highest
Current $ 5.92
$ 10.50 (+77.36%)
Average
$ 7.67 (+29.56%)
Lowest
$ 5.50 (-7.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Buy
Maintained
$ 10.50
+77.4%
09/24/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$ 10.00
+68.9%
08/31/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
09/01/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$ 7.00
+18.2%
08/04/2026
Charles Rhyee
TD Cowen
Hold
Maintained
$ 6.00
+1.4%
08/03/2026
Daniel Grosslight
Citi
Hold
Maintained
$ 7.50
+26.7%
08/03/2026
Peter Warendorf
Barclays
Hold
Maintained
$ 7.00
+18.2%
08/03/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
$ 6.00
+1.4%
07/30/2026
Brian Tanquilut
Jefferies
Hold
Maintained
$ 8.00
+35.1%
07/30/2026
David Grossman
Stifel Nicolaus
Hold
Maintained
$ 5.50
-7.1%
07/30/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$ 7.50
+26.7%
07/30/2026
Sean Dodge
BMO Capital
Hold
Reiterated
$ 7.00
+18.2%
07/29/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$ 10.00
+68.9%
07/29/2026
Ryan MacDonald
Needham
Hold
Reiterated
-
-
07/30/2026
David Larsen
BTIG
Hold
Reiterated
-
-
07/29/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
07/29/2026
David Roman
Goldman Sachs
Buy
Maintained
$ 8.00
+35.1%
05/27/2026
Kevin Caliendo
UBS
Hold
Maintained
$ 6.00
+1.4%
05/15/2026
Lisa Gill
J.P. Morgan
Hold
Reiterated
$ 7.00
+18.2%
03/13/2026
George Hill
Deutsche Bank
Buy
Upgraded
$ 11.00
+85.8%
03/10/2026
Scott Schoenhaus
KeyBanc
Hold
Maintained
-
-
02/27/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
$ 6.00
+1.4%
02/26/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
$ 9.00
+52%
02/26/2026
Last report
2026 оны 7-р сарын 29
Fiscal period
Q2 2026
-$ 0.20 / -$ 0.22
+10.84%beat
Revenue / Est. (USD)
606.93 сая / 615.99 сая
-1.47%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
626.44 сая
642.27 сая
613.84 сая
606.93 сая
Cost of goods sold
187.18 сая
197.05 сая
197.53 сая
190.84 сая
Cost of revenue
187.18 сая
197.05 сая
197.53 сая
190.84 сая
Research and development expenses
67.57 сая
71.61 сая
67.86 сая
62.86 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
318.78 сая
305.74 сая
304.90 сая
296.82 сая
Operating expense
474.72 сая
472.19 сая
465.05 сая
450.59 сая
Total operating expenses
661.90 сая
669.24 сая
662.57 сая
641.42 сая
Operating income
-35.46 сая
-26.97 сая
-48.73 сая
-34.50 сая
Other non operating income
-815.00 мян
378.00 мян
-196.00 мян
-2.19 сая
EBT including unusual items
-50.22 сая
-33.62 сая
-60.84 сая
-37.91 сая
EBT excluding unusual items
-33.72 сая
-24.59 сая
-47.80 сая
-35.32 сая
Income tax expense
-715.00 мян
-8.48 сая
3.00 сая
997.00 мян
Effective tax rate
1.42%
25.21%
-4.92%
-2.63%
Other operating expenses
-
-
-
-
Net income
-49.51 сая
-25.14 сая
-63.84 сая
-38.91 сая
Net profit margin
-7.90%
-3.91%
-10.40%
-6.41%
Earnings per share
-0.19
-0.10
-0.28
-0.20
Interest and investment income
7.08 сая
6.95 сая
6.49 сая
6.48 сая
Interest expense
-4.53 сая
-4.95 сая
-5.37 сая
-5.11 сая
Net interest expenses
2.56 сая
2.00 сая
1.12 сая
1.37 сая
Depreciation and amortization charges
2.61 сая
2.80 сая
2.46 сая
2.47 сая
EBITDA
10.68 сая
28.67 сая
5.48 сая
19.73 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс